![Alan Weichselbaum](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alan Weichselbaum
Direktor/Vorstandsmitglied bei
FINWISE BANCORP
Vermögen: 851 900 $ am 31.05.2026
Profil
Alan Weichselbaum is the founder of The Wexus Group LLC, founded in 2011.
Current jobs include Chairman & Managing Member at Gimmel Partners LP since 2012, Director at Young Israel of Lawrence-Cedarhurst, Director at Tony Power, and Director at FinWise Bancorp since 2022.
Former jobs include CEO, Acting Chief Financial Officer & CAO at Jesup & Lamont, Inc. from 2009 to 2012; Director at Rock Creek Pharmaceuticals, Inc. in 2010; Director at FinWise Bank; Director at FinWise Bancorp from 2015 to 2021; Analyst at Fulcrum Global Partners LLC in 2004; Manager-Financial Planning & Analysis at Philip Morris Capital Corp.; Chief Financial Officer & Treasurer at MIRA Pharmaceuticals, Inc. from 2025 to 2026; and Chief Financial Officer at Telomir Pharmaceuticals, Inc. from 2025 to 2026.
Education includes an undergraduate degree from Queens College in 1986 and an MBA from New York University in 1999.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
FINWISE BANCORP 0.43% | 21.04.2026 | 59’242 ( 0.43% ) | 851 900 $ | 31.05.2026 |
| 15.05.2025 | 0 ( -.--% ) | - $ | 31.05.2026 | |
| 15.05.2025 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Alan Weichselbaum
| Unternehmen | Position | Beginn |
|---|---|---|
| FINWISE BANCORP | Direktor/Vorstandsmitglied | 01.10.2022 |
Gimmel Partners LP | Vorsitzender | 01.10.2005 |
Young Israel of Lawrence-Cedarhurst | Direktor/Vorstandsmitglied | - |
Tony Power | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Alan Weichselbaum
| Unternehmen | Position | Ende |
|---|---|---|
| MIRA PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 06.06.2026 |
| TELOMIR PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 06.06.2026 |
| FINWISE BANCORP | Direktor/Vorstandsmitglied | 07.05.2021 |
FinWise Bank
 FinWise Bank Regional BanksFinance Provides state chartered commercial banking services | Direktor/Vorstandsmitglied | 07.05.2021 |
| ROCK CREEK PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 22.10.2010 |
Ausbildung von Alan Weichselbaum
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
86
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
Rock Creek Pharmaceuticals, Inc.
 Rock Creek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures a variety of pharmaceutical products | Health Technology |
Fulcrum Global Partners LLC
 Fulcrum Global Partners LLC Investment Banks/BrokersFinance Provides securities research analysis and trade execution services | Finance |
Queens College
 Queens College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Philip Morris Capital Corp.
 Philip Morris Capital Corp. Finance/Rental/LeasingFinance Functions as a financing subsidiary/special purpose entity | Finance |
Gimmel Partners LP | |
Young Israel of Lawrence-Cedarhurst | Commercial Services |
Tony Power | |
Jesup & Lamont, Inc.
 Jesup & Lamont, Inc. Investment Banks/BrokersFinance Provides securities brokerage, asset management and market services | Finance |
FinWise Bank
FinWise Bank Regional BanksFinance Provides state chartered commercial banking services | Finance |
FinWise Bancorp
 FinWise Bancorp Regional BanksFinance Operates as a bank holding company whose subsidiary provides banking services | Finance |
MIRA Pharmaceuticals, Inc.
 MIRA Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Develops and sells new molecular synthetic THC for the treatment of adult patients with anxiety and cognitive decline | Health Technology |
THE WEXUS GROUP LLC
 THE WEXUS GROUP LLC Miscellaneous Commercial ServicesCommercial Services Operates as a a financial firm that provides accounting, vendor management, bookkeeping, marketing strategies and consulting services | Commercial Services |
Telomir Pharmaceuticals, Inc.
 Telomir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops a novel small molecule as the first regulator of telomere length and genomic stability | Health Technology |
Wählen Sie MarketScreener 
